CTLA4 and neoplasm: The major tumor-extrinsic mechanism is compensation for PD-L1/PD-1 and/or CTLA-4/CD80/86 blockade through alternate immune checkpoints such as LAG-3, TIM-3, TIGIT, and VISTA [28].